1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Myocardial Infarction Therapeutics Market, By Product Type
5.1 Introduction
5.2 Analgesics
5.3 Antiplatelet agents
5.4 Vasodilators
5.5 Thrombolytics and anti-thrombotic agents
5.6 Glycoprotein IIb/IIIa inhibitors
5.7 Β adrenergic blockers
5.8 Angiotensin receptor antagonists
5.9 Angiotensin converting enzyme inhibitors
5.10 Antithrombotic agents
6 Global Myocardial Infarction Therapeutics Market, By Distribution channel
6.1 Introduction
6.2 Hospitals
6.3 Hospital Pharmacies
6.4 Drug Stores
6.5 Online drug stores
7 Global Myocardial Infarction Therapeutics Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Anthera Pharmaceuticals
9.2 AstraZeneca, Apotex Inc.
9.3 Bayer AG
9.4 Boehringer Ingelheim GmbH
9.5 Bristol-Myers Squibb Company
9.6 Capricor Inc.
9.7 Daiichi Sankyo Company Limited
9.8 GlaxoSmithKline Plc
9.9 Johnson & Johnson
9.10 Merck and Co. Inc.
9.11 Mylan N.V.
9.12 Novartis N.V.
9.13 Par Pharmaceutical Companies, Inc.
9.14 Pfizer Inc.
9.15 Portola Pharmaceuticals Inc.
9.16 Sandoz
9.17 Sanofi
9.18 The Medicines Company
List of Tables
Table 1 Global Myocardial Infarction Therapeutics Market Outlook, By Region (2015-2022) ($MN)
Table 2 Global Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 3 Global Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 4 Global Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 5 Global Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 6 Global Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 7 Global Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 8 Global Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 9 Global Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 10 Global Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 11 Global Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 12 Global Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 13 Global Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 14 Global Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 15 Global Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)
Table 16 North America Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 17 North America Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 18 North America Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 19 North America Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 20 North America Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 21 North America Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 22 North America Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 23 North America Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 24 North America Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 25 North America Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 26 North America Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 27 North America Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 28 North America Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 29 North America Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)
Table 30 Europe Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 31 Europe Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 32 Europe Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 33 Europe Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 34 Europe Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 35 Europe Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 36 Europe Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 37 Europe Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 38 Europe Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 39 Europe Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 40 Europe Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 41 Europe Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 42 Europe Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 43 Europe Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)
Table 44 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 45 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 46 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 47 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 48 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 49 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 50 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 51 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 52 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 53 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 54 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 55 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 56 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 57 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)
Table 58 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 59 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 60 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 61 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 62 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 63 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 64 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 65 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 66 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 67 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 68 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 69 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 70 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 71 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)
【レポートのキーワード】
心筋梗塞、心筋梗塞治療薬